Research on quaternary ammonium compounds (QACs) and their effectiveness against MRSA has shown promising results. Studies have found that QACs are able to effectively combat MRSA by disrupting the bacterial cell membrane and inhibiting its growth. Various methodologies, including in vitro and in vivo experiments, have been used to demonstrate the efficacy of QACs in killing MRSA strains. The implications of these findings are significant, as MRSA infections are becoming increasingly resistant to traditional antibiotics, making alternative treatments like QACs crucial in combating this dangerous pathogen. Further research is needed to explore the full potential of QACs in treating MRSA infections and to develop new strategies for combating antibiotic-resistant bacteria.